ArticleJournal of oral and maxillofacial pathology : JOMFP
A comparative analysis of CDK1 expression in normal mucosa, oral epithelial dysplasia and oral squamous cell carcinoma - An immunohistochemical study.
Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral squamous cell carcinoma (OSCC) accounts for about 90% of oral malignancies, with a higher occurrence among males than females. Use of molecular biomarkers acts as a reliable predictor of tumour aggressiveness. CDK1 modulates the centrosome cycle and mitotic onset, promoting G2-M transition and regulation of G1-S transition associated with multiple interphase cyclins. Inhibiting CDK1 and its substrates could increase the efficacy of OSCC treatment by overcoming immune or apoptotic resistance. Aim: To compare the immunohistochemical (IHC) expression of CDK1 in normal mucosa (NOM), oral epithelial dysplasia (OED), OSCC, to assess the prognostic value of CDK1 in OSCC and to compare and correlate those three groups. Materials and Methods: This study includes 55 cases, which consist of 20 cases of OSCC, 20 cases of OED and 15 cases of NOM, which were retrieved from the archives of our department and were subjected to IHC staining. The Mann-Whitney test was utilised to find out the association among the categorical variables. The Wilcoxon test was used to compare the continuous parameters between three groups. Results: On IHC analysis, CDK1 expression was found to be 80% positive in the OED group, 85% in the OSCC group, and negative in the NOM group. Negative CDK1 expression was seen in NOM. Conclusion: CDK1 can be used as a predictor in the prognosis of OSCC and determine the degree of malignancy at an early stage of OSCC. Targeting CDK1 interacting proteins and their signalling pathways produces less toxicity in treating oral carcinogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.